A detailed history of Garrison Asset Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Garrison Asset Management, LLC holds 11,475 shares of NVO stock, worth $1.37 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares
11,475
Previous 11,992 4.31%
Holding current value
$1.37 Million
Previous $1.54 Million 6.37%
% of portfolio
0.89%
Previous 0.82%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$122.71 - $146.91 $63,441 - $75,952
-517 Reduced 4.31%
11,475 $1.64 Million
Q1 2024

May 10, 2024

SELL
$102.11 - $135.92 $4,799 - $6,388
-47 Reduced 0.39%
11,992 $1.54 Million
Q4 2023

May 24, 2024

SELL
$87.78 - $105.45 $20,716 - $24,886
-236 Reduced 1.92%
12,039 $1.25 Million
Q4 2023

Feb 01, 2024

SELL
$87.78 - $105.45 $20,716 - $24,886
-236 Reduced 1.92%
12,039 $1.25 Million
Q3 2023

May 24, 2024

BUY
$90.94 - $199.54 $556,552 - $1.22 Million
6,120 Added 99.43%
12,275 $1.12 Million
Q3 2023

Oct 23, 2023

BUY
$90.94 - $199.54 $556,552 - $1.22 Million
6,120 Added 99.43%
12,275 $1.12 Million
Q2 2023

May 24, 2024

BUY
$155.98 - $172.65 $26,516 - $29,350
170 Added 2.84%
6,155 $996,000
Q2 2023

Aug 03, 2023

BUY
$155.98 - $172.65 $26,516 - $29,350
170 Added 2.84%
6,155 $995,000
Q1 2023

May 24, 2024

SELL
$132.34 - $159.14 $11,910 - $14,322
-90 Reduced 1.48%
5,985 $952,000
Q1 2023

Apr 28, 2023

SELL
$132.34 - $159.14 $11,910 - $14,322
-90 Reduced 1.48%
5,985 $952,000
Q4 2022

May 24, 2024

SELL
$102.55 - $135.33 $606,788 - $800,747
-5,917 Reduced 49.34%
6,075 $822,000
Q3 2022

Oct 21, 2022

SELL
$95.28 - $116.93 $16,388 - $20,111
-172 Reduced 2.75%
6,075 $605,000
Q2 2022

Aug 08, 2022

SELL
$103.24 - $121.81 $21,267 - $25,092
-206 Reduced 3.19%
6,247 $696,000
Q1 2022

May 09, 2022

BUY
$93.1 - $112.54 $3,910 - $4,726
42 Added 0.66%
6,453 $717,000
Q4 2021

Jan 25, 2022

SELL
$95.88 - $117.08 $92,524 - $112,982
-965 Reduced 13.08%
6,411 $718,000
Q3 2021

Oct 20, 2021

SELL
$84.42 - $106.62 $6,331 - $7,996
-75 Reduced 1.01%
7,376 $708,000
Q2 2021

Jul 21, 2021

SELL
$67.66 - $84.76 $47,294 - $59,247
-699 Reduced 8.58%
7,451 $624,000
Q1 2021

Apr 21, 2021

BUY
$67.06 - $75.82 $60,354 - $68,238
900 Added 12.41%
8,150 $549,000
Q4 2020

Feb 02, 2021

SELL
$63.89 - $73.8 $282,074 - $325,827
-4,415 Reduced 37.85%
7,250 $506,000
Q2 2020

Aug 06, 2020

SELL
$58.54 - $67.94 $28,391 - $32,950
-485 Reduced 3.99%
11,665 $764,000
Q1 2020

May 04, 2020

SELL
$49.46 - $64.78 $34,374 - $45,022
-695 Reduced 5.41%
12,150 $731,000
Q4 2019

Feb 10, 2020

BUY
$49.86 - $58.26 $16,703 - $19,517
335 Added 2.68%
12,845 $743,000
Q4 2018

Feb 06, 2019

BUY
$41.54 - $47.25 $35,724 - $40,635
860 Added 7.38%
12,510 $576,000
Q4 2018

Feb 05, 2019

SELL
$41.54 - $47.25 $23,262 - $26,460
-560 Reduced 4.59%
11,650 $485,000
Q4 2017

Jan 30, 2018

BUY
$47.53 - $53.73 $28,993 - $32,775
610 Added 5.26%
12,210 $655,000
Q3 2017

Oct 30, 2017

BUY
$41.15 - $49.22 $477,340 - $570,952
11,600
11,600 $559,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $269B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Garrison Asset Management, LLC Portfolio

Follow Garrison Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Garrison Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Garrison Asset Management, LLC with notifications on news.